Ligand Pharmaceuticals Inc (LGND)

85.92 -1.49  -1.70% NASDAQ Nov 27, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/05/2021 Earnings Ligand Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release
02/05/2021 16:30 EST Misc Ligand Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020
10/30/2020 Earnings Ligand Pharmaceuticals Inc Third Quarter Earnings Result for 2020
10/30/2020 08:30 EDT Misc Ligand Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
08/03/2020 08:30 EDT Misc Ligand Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
08/03/2020 Earnings Ligand Pharmaceuticals Inc Second Quarter Earnings Result for 2020
06/10/2020 08:30 PDT Misc Ligand Pharmaceuticals Inc Annual General Meeting for 2019
05/06/2020 Earnings Ligand Pharmaceuticals Inc First Quarter Earnings Result for 2020
05/06/2020 Misc Ligand Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
02/27/2020 Misc Ligand Pharmaceuticals Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.ligand.com
  • Investor Relations URL: http://investor.ligand.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 05, 2021
  • Last Earnings Release: Oct. 30, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jul. 02, 2010
  • Description: Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Top Fund Holders

Symbol Name Weighting
PXSAX Pax Small Cap A 3.31%
BUISX Buffalo Small Cap Institutional 2.48%
VEVFX Vanguard Explorer Value Inv 1.73%
BUITX Buffalo Discovery Institutional 1.55%
WBSRX William Blair Small Cap Growth R6 1.36%
DCCRX Delaware Small Cap Core R 1.09%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.